European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Oritavancin

European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Oritavancin

[Marketwired] – The Medicines Company today announced that the European Medicines Agency has accepted for review a marketing authorization application for the investigational intravenous antibiotic, oritavancin, for the … more

View todays social media effects on MDCO

View the latest stocks trending across Twitter. Click to view dashboard

See who The is hiring next, click here to view

Share this post